CO5460266A1 - Novedosos analogos de la somatostatina - Google Patents

Novedosos analogos de la somatostatina

Info

Publication number
CO5460266A1
CO5460266A1 CO00063458A CO00063458A CO5460266A1 CO 5460266 A1 CO5460266 A1 CO 5460266A1 CO 00063458 A CO00063458 A CO 00063458A CO 00063458 A CO00063458 A CO 00063458A CO 5460266 A1 CO5460266 A1 CO 5460266A1
Authority
CO
Colombia
Prior art keywords
compounds
somatostatin
analogs
somatostatine
new
Prior art date
Application number
CO00063458A
Other languages
English (en)
Inventor
John Lister-James
Richard T Dean
Daniel A Pearson
David M Wilson
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of CO5460266A1 publication Critical patent/CO5460266A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La invención provee novedosos farmacóforos basados en péptidos y compuestos que se enlazan con gran afinidad a los receptores de la somatostatina y que presentan propiedades farmacocinéticas mejoradas frente a los análogos de somatostatina conocidos. Los farmacóforos y compuestos de la invención pueden ser utilizados en forma marcada o no marcada para diagnosticar y/o tratar enfermedades de responsabilidad de la somatostatina. La invención también provee radiofármacos y equipos que comprenden estos compuestos, como también métodos para diagnosticar y/o tratar enfermedades mediadas por los receptores de la somatostatina.
CO00063458A 1999-08-27 2000-08-24 Novedosos analogos de la somatostatina CO5460266A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15100199P 1999-08-27 1999-08-27
US09/397,792 US6358491B1 (en) 1999-08-27 1999-09-16 Somatostatin analogs

Publications (1)

Publication Number Publication Date
CO5460266A1 true CO5460266A1 (es) 2004-11-30

Family

ID=26848228

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00063458A CO5460266A1 (es) 1999-08-27 2000-08-24 Novedosos analogos de la somatostatina

Country Status (12)

Country Link
US (1) US6358491B1 (es)
EP (1) EP1208116B1 (es)
JP (1) JP2003517037A (es)
AT (1) ATE393781T1 (es)
AU (1) AU782873B2 (es)
CA (1) CA2383936A1 (es)
CO (1) CO5460266A1 (es)
DE (1) DE60038739T2 (es)
ES (1) ES2305000T3 (es)
PE (1) PE20010516A1 (es)
TW (1) TWI243178B (es)
WO (1) WO2001044177A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE395002T1 (de) * 1997-11-24 2008-05-15 Univ Louisiana State Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe
EP1283216A1 (en) * 2001-08-10 2003-02-12 Mallinckrodt Inc. Somatostatin analogues binding to all somatostatin receptor subtypes and their use
DE10215336A1 (de) 2002-03-28 2003-10-23 Schering Ag N-Methyl-Homocysteine und ihre Verwendung sowie Verfahren zu ihrer Herstellung
WO2003057214A1 (en) * 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
JP5395327B2 (ja) 2003-09-17 2014-01-22 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 機構ベースの標的化した膵臓β細胞画像化および治療
EP1700608A1 (en) 2005-03-10 2006-09-13 Schering AG Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
JP2008538204A (ja) * 2005-03-10 2008-10-16 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化側鎖を含む放射性標識複合体キレート剤
EP1717247A1 (en) * 2005-04-28 2006-11-02 Schering AG Cyclic peptides binding to the somatostatin receptor
WO2006114324A1 (en) * 2005-04-28 2006-11-02 Schering Ag Compounds comprising cyclized somatostatin receptor binding peptides
EP1717219A1 (en) * 2005-04-28 2006-11-02 Schering AG Orthogonally protected bifunctional amino acid
US20070025910A1 (en) 2005-07-29 2007-02-01 Norenberg Jeffrey P Anticancer therapy
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
RU2528414C1 (ru) * 2013-01-25 2014-09-20 Закрытое Акционерное Общество "Фарм-Синтез" Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
US20160031935A1 (en) * 2013-03-15 2016-02-04 Adaerata, Limited Partnership Small molecule modulators of pcsk9 and methods of use thereof
KR102062025B1 (ko) 2014-06-30 2020-01-03 타베다 세라퓨틱스, 인코포레이티드 표적화된 콘주게이트 및 입자 및 그것의 제형
AU2016343817B2 (en) 2015-10-28 2021-05-27 Tva (Abc), Llc SSTR-targeted conjugates and particles and formulations thereof
DK3568205T3 (da) 2017-01-12 2023-10-09 Radiomedix Inc Behandling af cancerceller, der overeksprimerer somatostatinreceptorer ved at anvende radioisotop-chelaterede ocreotid-derivater

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310518A (en) 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4486415A (en) 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4522813A (en) 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
EP0222578A3 (en) 1985-11-06 1990-04-04 Merck & Co. Inc. Use of cyclic somatostatin analogues in the treatment of immediate hypersensitivity diseases
US5776894A (en) 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5985240A (en) 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
ES2158897T3 (es) * 1993-06-23 2001-09-16 Diatide Inc Peptidos radiomarcados derivados de somatostatina y utilizados en procedimientos de formacion de imagenes y terapeuticos.
GB9417873D0 (en) 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5597894A (en) 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5770687A (en) 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US5830431A (en) 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
MY147327A (en) 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
US5708135A (en) 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
AT405906B (de) 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Also Published As

Publication number Publication date
ATE393781T1 (de) 2008-05-15
CA2383936A1 (en) 2001-06-21
US6358491B1 (en) 2002-03-19
WO2001044177A3 (en) 2002-03-28
AU782873B2 (en) 2005-09-08
EP1208116B1 (en) 2008-04-30
WO2001044177A2 (en) 2001-06-21
JP2003517037A (ja) 2003-05-20
PE20010516A1 (es) 2001-04-29
TWI243178B (en) 2005-11-11
DE60038739D1 (de) 2008-06-12
AU4865901A (en) 2001-06-25
EP1208116A2 (en) 2002-05-29
ES2305000T3 (es) 2008-11-01
DE60038739T2 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
CO5460266A1 (es) Novedosos analogos de la somatostatina
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
NO20022655D0 (no) <Beta>-2-adrenerge reseptoragonister
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
DE69942753D1 (de) Peptidantagonist von Zonulin und dessen Verwendung
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
EP1461061A4 (en) COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
ATE423769T1 (de) Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten
AUPO755097A0 (en) Receptor agonist and antagonist
HUP0203567A2 (hu) APRIL-receptor (BCMA) és alkalmazásai
DK1085896T3 (da) Somatostatinanaloger cykliseret med konformationelt begrænset skelet
IS5543A (is) Nýr G próteintengdur viðtaki
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
EP1383919A4 (en) METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDE AS MACROPHAGE MIGRATION INHIBITION FACTOR RECEPTOR
WO2003048305A3 (en) Receptors and membrane-associated proteins
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
WO2003070902A3 (en) Receptors and membrane-associated proteins
ATE273389T1 (de) Rezeptor des y-y5 neuropeptids
SE9702794D0 (sv) New compounds
DE60139770D1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
WO2004100774A3 (en) Receptors and membrane-associated proteins
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2004029218A3 (en) Receptors and membrane-associated proteins
WO2004060282A3 (en) Uses of the snorf207 receptor

Legal Events

Date Code Title Description
FC Application refused